Immunohistochemistry showed that these colorectal tumor nodules expressed CASP4 in lung metastases, which was enhanced by SCGB3A2 administration and correlated with the inhibition of tumors (Fig. 4D for HCT116, data not shown). Here, CASP4 is linked to colorectal neoplasm.